317 related articles for article (PubMed ID: 12543104)
21. The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells.
Griggs ND; Agersborg SS; Noelle RJ; Ledbetter JA; Linsley PS; Tung KS
J Exp Med; 1996 Mar; 183(3):801-10. PubMed ID: 8642284
[TBL] [Abstract][Full Text] [Related]
22. The role of CD40 ligand in costimulation and T-cell activation.
Grewal IS; Flavell RA
Immunol Rev; 1996 Oct; 153():85-106. PubMed ID: 9010720
[TBL] [Abstract][Full Text] [Related]
23. Selective blockade of CD28 and not CTLA-4 with a single-chain Fv-alpha1-antitrypsin fusion antibody.
Vanhove B; Laflamme G; Coulon F; Mougin M; Vusio P; Haspot F; Tiollier J; Soulillou JP
Blood; 2003 Jul; 102(2):564-70. PubMed ID: 12649149
[TBL] [Abstract][Full Text] [Related]
24. CD4 help-independent induction of cytotoxic CD8 cells to allogeneic P815 tumor cells is absolutely dependent on costimulation.
Zhan Y; Corbett AJ; Brady JL; Sutherland RM; Lew AM
J Immunol; 2000 Oct; 165(7):3612-9. PubMed ID: 11034363
[TBL] [Abstract][Full Text] [Related]
25. Induction of CD4 T cell changes in murine AIDS is dependent on costimulation and involves a dysregulation of homeostasis.
Yen MH; Lepak N; Swain SL
J Immunol; 2002 Jul; 169(2):722-31. PubMed ID: 12097374
[TBL] [Abstract][Full Text] [Related]
26. Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Gray GS; Vallera DA
Blood; 1995 May; 85(9):2607-18. PubMed ID: 7537122
[TBL] [Abstract][Full Text] [Related]
27. Generation of protective immunity against an immunogenic carcinoma requires CD40/CD40L and B7/CD28 interactions but not CD4(+) T cells.
Eck SC; Turka LA
Cancer Immunol Immunother; 1999 Sep; 48(6):336-41. PubMed ID: 10473809
[TBL] [Abstract][Full Text] [Related]
28. Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance.
Boussiotis VA; Gribben JG; Freeman GJ; Nadler LM
Curr Opin Immunol; 1994 Oct; 6(5):797-807. PubMed ID: 7530013
[TBL] [Abstract][Full Text] [Related]
29. Limited importance of CD40/CD40L interaction in the B7-dependent generation of anti-MOPC-315 cytotoxic T lymphocyte activity by tumor bearer splenic cells stimulated in vitro in the presence of tumor necrosis factor.
Kalinichenko TV; Mokyr MB
Cancer Immunol Immunother; 1998 Aug; 46(6):293-303. PubMed ID: 9756413
[TBL] [Abstract][Full Text] [Related]
30. Costimulation through OX40 is crucial for induction of an alloreactive human T-cell response.
Ukyo N; Hori T; Yanagita S; Ishikawa T; Uchiyama T
Immunology; 2003 Jun; 109(2):226-31. PubMed ID: 12757617
[TBL] [Abstract][Full Text] [Related]
31. CD28-independent costimulation of T cells in alloimmune responses.
Yamada A; Kishimoto K; Dong VM; Sho M; Salama AD; Anosova NG; Benichou G; Mandelbrot DA; Sharpe AH; Turka LA; Auchincloss H; Sayegh MH
J Immunol; 2001 Jul; 167(1):140-6. PubMed ID: 11418642
[TBL] [Abstract][Full Text] [Related]
32. Blockade of costimulatory molecules on dendritic cells: implications for tolerance induction.
Luke PP; Thomson AW
Transplant Proc; 2001; 33(1-2):507-8. PubMed ID: 11266929
[No Abstract] [Full Text] [Related]
33. Synergy between cyclosporin A and a monoclonal antibody to B7 in blocking alloantigen-induced T-cell activation.
Van Gool SW; Ceuppens JL; Walter H; de Boer M
Blood; 1994 Jan; 83(1):176-83. PubMed ID: 7506079
[TBL] [Abstract][Full Text] [Related]
34. CD28/B7 costimulation: a review.
Greenfield EA; Nguyen KA; Kuchroo VK
Crit Rev Immunol; 1998; 18(5):389-418. PubMed ID: 9784967
[TBL] [Abstract][Full Text] [Related]
35. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
Gao D; Li J; Orosz CG; Bumgardner GL
Hepatology; 2000 Nov; 32(5):1018-28. PubMed ID: 11050052
[TBL] [Abstract][Full Text] [Related]
36. The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells.
Seo SJ; Fields ML; Buckler JL; Reed AJ; Mandik-Nayak L; Nish SA; Noelle RJ; Turka LA; Finkelman FD; Caton AJ; Erikson J
Immunity; 2002 Apr; 16(4):535-46. PubMed ID: 11970877
[TBL] [Abstract][Full Text] [Related]
37. Induction of immunologic tolerance for allogeneic hematopoietic cell transplantation.
Appleman LJ; Tzachanis D; Grader-Beck T; Van Puijenbroek AA; Boussiotis VA
Leuk Lymphoma; 2002 Jun; 43(6):1159-67. PubMed ID: 12152983
[TBL] [Abstract][Full Text] [Related]
38. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
39. Differential graft-versus-leukaemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxis.
Ohata J; Sakurai J; Saito K; Tani K; Asano S; Azuma M
Clin Exp Immunol; 2002 Jul; 129(1):61-8. PubMed ID: 12100023
[TBL] [Abstract][Full Text] [Related]
40. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]